Tumor Necrosis Factor Receptor Superfamily Member 18 Market

Tumor Necrosis Factor Receptor Superfamily Member 18 Market contains market size and forecasts of Tumor Necrosis Factor Receptor Superfamily Member 18 in global, including the following market information:
Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Tumor Necrosis Factor Receptor Superfamily Member 18 companies in 2021 (%)
The global Tumor Necrosis Factor Receptor Superfamily Member 18 market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
AMG-228 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Tumor Necrosis Factor Receptor Superfamily Member 18 include Ablynx NV, Amgen Inc, Apogenix GmbH, Bristol-Myers Squibb Company, Five Prime Therapeutics Inc, Incyte Corp, MedImmune LLC, Merck & Co Inc and Novartis AG, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Tumor Necrosis Factor Receptor Superfamily Member 18 manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Segment Percentages, by Type, 2021 (%)
AMG-228
BMS-986156
FPA-154
GWN-323
INCAGN-1876
Others
Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Segment Percentages, by Application, 2021 (%)
Melanoma
Non-Small Cell Lung Cancer
Gastric Cancer
Blood Cancer
Others
Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tumor Necrosis Factor Receptor Superfamily Member 18 revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Tumor Necrosis Factor Receptor Superfamily Member 18 revenues share in global market, 2021 (%)
Key companies Tumor Necrosis Factor Receptor Superfamily Member 18 sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Tumor Necrosis Factor Receptor Superfamily Member 18 sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ablynx NV
Amgen Inc
Apogenix GmbH
Bristol-Myers Squibb Company
Five Prime Therapeutics Inc
Incyte Corp
MedImmune LLC
Merck & Co Inc
Novartis AG
OncoMed Pharmaceuticals Inc
Regeneron Pharmaceuticals Inc